400 related articles for article (PubMed ID: 15811488)
1. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
Teale JD; Wark G
Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
[TBL] [Abstract][Full Text] [Related]
3. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V
Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670
[TBL] [Abstract][Full Text] [Related]
4. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor.
Mukherjee S; Diver M; Weston PJ
Acta Oncol; 2005; 44(7):761-3. PubMed ID: 16227169
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].
van Wijngaarden P; Janssen JA; de Man RA
Ned Tijdschr Geneeskd; 2002 May; 146(18):859-62. PubMed ID: 12038225
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
11. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
Liang LJ; Luo SM; Hu WJ
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience in identical twins discordant for adult-onset growth hormone deficiency.
Simpson H; Camcho-Hübner C; Sönksen P; Russell-Jones D
J Endocrinol Invest; 1999; 22(5 Suppl):61-3. PubMed ID: 10442573
[TBL] [Abstract][Full Text] [Related]
13. [Optimal time for the administration of rhGH in severely burned patients--analysis of the dynamic changes of IGF axis and blood sugar].
Han CM; Xie WG; Xu RF; Chen GX
Zhonghua Shao Shang Za Zhi; 2003 Aug; 19(4):213-5. PubMed ID: 14514400
[TBL] [Abstract][Full Text] [Related]
14. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M
Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia.
Baxter RC
Horm Res; 1996; 46(4-5):195-201. PubMed ID: 8950621
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH).
Teale JD; Marks V
Clin Endocrinol (Oxf); 1998 Oct; 49(4):491-8. PubMed ID: 9876347
[TBL] [Abstract][Full Text] [Related]
17. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial.
Li N; Zhou L; Zhang B; Dong P; Lin W; Wang H; Xu R; Ding H
Dig Liver Dis; 2008 Jul; 40(7):554-9. PubMed ID: 18164672
[TBL] [Abstract][Full Text] [Related]
19. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.
de Groot JW; Rikhof B; van Doorn J; Bilo HJ; Alleman MA; Honkoop AH; van der Graaf WT
Endocr Relat Cancer; 2007 Dec; 14(4):979-93. PubMed ID: 18045950
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
